CGS : Lawsuit against gene patents can proceed: judge

A lawsuit challenging patents on two human genes associated with hereditary breast and ovarian cancer can move forward, a U.S. federal judge ruled on Monday.

A lawsuit brought by the American Civil Liberties Union challenged patents held by Myriad Genetics and the University of Utah Research Foundation on grounds that genes are "products of nature" and cannot be patented.

U.S. District Judge Robert Sweet declined to dismiss the case, ruling its outcome could have implications for "the health of millions of women facing the specter of breast cancer" as well as the "future course of biomedical research."

A spokeswoman at the U.S. Attorney's office in New York, which represents the U.S. Patent and Trademark Office, and a lawyer for Myriad Genetics had no immediate comment.

The lawsuit was brought in Manhattan federal court in May on behalf of women's health groups, geneticists and scientific associations representing approximately 150,000 researchers, pathologists and laboratory professionals, the ACLU said.

This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of biotechnology and public policy issues. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.